missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human 4-1BB/TNFRSF9 Fc Avi-tag Protein
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human 4-1BB Ligand/TNFSF9 His-tag (Catalog # 2295-4L ) is immobilized at 0.01 μg/mL (100 μL/well), Biotinylated Recombinant Human 4-1BB/TNFRSF9/CD137 Fc Chimera Avi-tag (Catalog # AVI10536) binds with an ED50 of 0.125-1 ng/mL.
Specifications
Specifications
| Accession Number | Q07011.1 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gene ID (Entrez) | 3604 |
| Molecular Weight (g/mol) | M.W.-observed: 56-66 kDa, under reducing conditions, M.W.-theroretical: 46 kDa |
| Quantity | 50 μg |
| Source | Human embryonic kidney cell, HEK293-derived human 4-1 BB/TNFRSF9/CD137 protein Human 4-1 BB/TNFRSF9/CD137 (Leu24-Gln186) (c-terminus) Accession # Q07011.1 IEGRMD Human IgG1 (Pro100-Lys330) Avi-tag N-terminus C-terminμs |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Gene Alias | 41 BB, 4-1 BB, 4-1 BB ligand receptor, CD137, CD137 antigen, CD137MGC2172, CDw137, FLJ43501, ILA, ILAhomolog of mouse 4-1 BB, induced by lymphocyte activation (ILA), interleukin-activated receptor, homolog of mouse Ly63, receptor protein 4-1 BB, T cell antigen ILA, T-cell antigen 4-1 BB homolog, T-cell antigen ILA, TNFRSF9, tumor necrosis factor receptor superfamily member 9, tumor necrosis factor receptor superfamily, member 9 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?